New York Times Co (NYT) Stock Price Today
Aura AI Summary
Key Stats
- $12.21BMarket Cap
- -Volume
- MediaSector
- $85.8652W High
- $53.6252W Low
- -Typical Hold Time
- $11.61BEnterprise Value
- 1.22%Div Yield
- -Trading Activity
Track New York Times Co (NYT) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, New York Times Co has traded between a low of $53.62 and a high of $85.86, highlighting its annual price range. Buy and sell New York Times Co shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About New York Times Co
New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as nytimes and various smartphone applications. Circulation of The New York Times is the source of revenue for the company, followed by print and digital advertising and its paid digital-only subscription to The New York Times. The company has a daily print circulation of over 500,000 and 1,000,000 on Sundays. The source of growth for The New York Times is its digital subscription service, which has over 1,000,000 paid users.
Most Recent News
Global advanced carbon materials market forecasted to grow through 2037 driven by EVs, renewables, aerospace, and AI.
A new market report forecasts significant growth in the global advanced carbon materials sector through 2037, driven by rising demand in electric vehicles, renewable energy, aerospace, defense, and AI infrastructure. The report covers 16 material cat...

Court reveals Abacus misled investors with flawed life expectancy data in life settlements case
A U.S. court unsealed documents showing Abacus Global Management relied on inaccurate, short life expectancy estimates from Lapetus Solutions, misleading investors about the value of life settlement policies. The evidence reveals Lapetus had an actua...

PROCEPT BioRobotics faces securities fraud lawsuit ahead of earnings report with expected loss.
PROCEPT BioRobotics is confronting a securities fraud class action lawsuit alleging it artificially boosted sales by pulling future sales into current quarters. This legal issue caused an 18% drop in its stock price. The company is set to report earn...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.